India Pharmaceuticals and Healthcare Report

May, 2016   |   118  Pages   |   BMI Pharmaceuticals and Healthcare   |   Format : PDF

BMI View: The tough operating environment for multinational drugmakers in India will see little improvement over the medium term. Designated as a 'Priority Watch List Country' for PhRMA's Special 301 submission for 2016, the issues raised largely mirrored those touched upon in the 2015 submission, such as low levels of intellectual property and challenges in market access. As a result of these factors, innovative firms will adopt a cautious approach to India, which remains attractive due to its large medicine market size.

Headline Expenditure Projections
Pharmaceuticals: INR1,065bn (USD16bn) in 2015 to INR1,191bn (17bn) by 2016; +11.8% in local currency terms and 5.1% in US dollar terms. Forecast unchanged from last quarter.
Healthcare: INR6,695bn (USD104bn) in 2015 to INR7,561bn (USD110bn) by 2016; +12.9% in local currency terms and 6.2% in US dollar terms. Forecast revised upwards from last quarter.

BMI Industry View ....... 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (India 2014-2020)   7
SWOT .... 9
Industry Forecast ...... 11
Pharmaceutical Market Forecast  11
Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2012-2020)  . . . 13
Healthcare Market Forecast ...... 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020). . . . 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)        . . 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)         . . 18
Prescription Drug Market Forecast .... 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)         . . . . 21
Patented Drug Market Forecast . 22
Table: Selected Patent Developments Affecting Drugmakers      23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2012-2020). . 25
Generic Drug Market Forecast .. 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2012-2020). . . 27
OTC Medicine Market Forecast . 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2012-2020)      . . . . 29
Pharmaceutical Trade Forecast . 30
Table: Pharmaceutical Trade Data And Forecasts (India 2014-2020)    . . 31
Table: Pharmaceutical Trade Data And Forecasts local currency (India 2014-2020) . . . . 32
Industry Risk/Reward Index ..... 33
Asia Pacific Risk/Reward Index - Q3 2016 .... 33
India Risk/Reward Index ... 39
Rewards ....... 39
Risks .... 39
Regulatory Review .... 41
Intellectual Property Issues ...... 45
Table: History Of The Indian Patent System        . . . . . 46
Table: Special 301 Submission: Issues Raised For India      . . . . 47
Table: A Series Of Setbacks For Innovative Pharmaceutical Firms    . . . . . 47
Pricing Regime ...... 51
Market Overview ....... 56
Healthcare Sector .. 56
Table: Healthcare Resources (India 2010-2015)        . 59
Table: Healthcare Personnel (India 2010-2015)        . 59
Table: Healthcare Activity (India 2010-2015)        . . . . 60
Clinical Trials ....... 62
Epidemiology  64
Table: Estimated Number Of New Cases Of Cancer In India      66
Competitive Landscape .... 67
Research-Based Industry . 67
Table: Ordinary Members Of OPPI. . 67
Table: Multinational Market Activity. 68
Pharmaceutical Distribution .... 70
Pharmaceutical Retail Sector ... 70
Company Profile  72
Aurobindo Pharmaceutical  72
Cipla ..... 75
Dr. Reddy's Laboratories .. 79
GlaxoSmithKline ..... 83
Merck & Co .... 88
Novartis . 91
Pfizer .... 95
Sanofi India .. 100
Sun Pharmaceutical ....... 104
Demographic Forecast ... 107
Table: Population Headline Indicators (India 1990-2025)      . 108
Table: Key Population Ratios (India 1990-2025)       . . . . . 108
Table: Urban/Rural Population & Life Expectancy (India 1990-2025)    . 109
Table: Population By Age Group (India 1990-2025)       . . 109
Table: Population By Age Group % (India 1990-2025)      . . . . . 110
Glossary ... 112
Methodology .... 114
Pharmaceutical Expenditure Forecast Model .... 114
Healthcare Expenditure Forecast Model ... 114
Notes On Methodology .. 115
Risk/Reward Index Methodology ..... 116
Index Overview .... 117
Table: Pharmaceutical Risk/Reward Index Indicators       117
Indicator Weightings .... 118

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonindia.com
Fax Number: +91 22 27812707

Follow Us On: